Nitroflurbiprofen (NicOx)
- PMID: 15202730
Nitroflurbiprofen (NicOx)
Abstract
Nitroflurbiprofen is a nitrosylated flurbiprofen analog under development by NicOx for the potential treatment of urinary incontinence, Alzheimer's disease (AD) and the prevention and treatment of accelerated bone resorption associated with disorders such as osteoporosis, inflammatory joint disease and Paget's disease. In addition, a topical formulation of nitroflurbiprofen is under development for the potential treatment of dermatological disorders, including contact urticaria. By 1999, nitroflurbiprofen was in phase IIa trials for urinary incontinence, Paget's disease and osteoporosis, and phase II trials of the topical formulation were underway in contact urticaria by March 2002. Phase I trials for AD had commenced by May 2003, and in September 2003, NicOx was intending to conduct further phase II trials for micturition disorders in 2003.
Similar articles
-
Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.Gastroenterology. 2007 Feb;132(2):709-19. doi: 10.1053/j.gastro.2006.12.041. Epub 2006 Dec 20. Gastroenterology. 2007. PMID: 17258737
-
Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.IDrugs. 2007 Feb;10(2):121-33. IDrugs. 2007. PMID: 17285465 Review.
-
NCX-4016 NicOx.Curr Opin Investig Drugs. 2003 Sep;4(9):1126-39. Curr Opin Investig Drugs. 2003. PMID: 14582459 Review.
-
Nitroflurbiprofen NicOx SA.IDrugs. 1998 Nov;1(7):807-12. IDrugs. 1998. PMID: 18465650
-
Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.Brain Res Brain Res Rev. 2005 Apr;48(2):400-8. doi: 10.1016/j.brainresrev.2004.12.029. Epub 2005 Jan 28. Brain Res Brain Res Rev. 2005. PMID: 15850679 Review.
Cited by
-
Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat.Br J Pharmacol. 2006 Apr;147(8):966-74. doi: 10.1038/sj.bjp.0706696. Br J Pharmacol. 2006. PMID: 16491094 Free PMC article.
-
Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy.Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):264-9. doi: 10.1073/pnas.0608277104. Epub 2006 Dec 20. Proc Natl Acad Sci U S A. 2007. PMID: 17182743 Free PMC article.
-
Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline?Int Urogynecol J. 2015 May;26(5):629-40. doi: 10.1007/s00192-014-2557-9. Epub 2014 Nov 7. Int Urogynecol J. 2015. PMID: 25377296 Review.